Pasar al contenido principal

PSEUDOGENES COMO ARN ONCOFETALES LARGOS NO CODIFICANTES: CARACTERIZACION FUNCIONAL E IMPLICACIONES PARA LA TERAPIA CONTRA EL CANCER.

PID2019-111658RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenetic Regulation of DLK1-DIO3 Region in Thyroid Carcinoma

  • Alves, Leticia F.
  • da Silva, Isabelle N.
  • de Mello, Diego Claro|||0000-0002-6405-0635
  • Fuziwara, Cesar S.|||0000-0002-0567-5432
  • Guil, Sonia|||0000-0002-2257-3331
  • Esteller, M|||0000-0003-4490-6093
  • Geraldo, Murilo|||0000-0002-9418-6103
Non-coding RNAs (ncRNAs) have emerged as pivotal regulators in cellular biology, dispelling their former perception as 'junk transcripts'. Notably, the DLK1-DIO3 region harbors numerous ncRNAs, including long non-coding RNAs (lncRNAs) and over 50 microRNA genes. While papillary thyroid cancer showcases a pervasive decrease in DLK1-DIO3-derived ncRNA expression, the precise mechanisms driving this alteration remain elusive. We hypothesized that epigenetic alterations underlie shifts in ncRNA expression during thyroid cancer initiation and progression. This study aimed to elucidate the epigenetic mechanisms governing DLK1-DIO3 region expression in this malignancy. We have combined the analysis of DNA methylation by bisulfite sequencing together with that of histone modifications through ChIP-qPCR to gain insights into the epigenetic contribution to thyroid cancer in cell lines representing malignancies with different genetic backgrounds. Our findings characterize the region's epigenetic signature in thyroid cancer, uncovering distinctive DNA methylation patterns, particularly within CpG islands on the lncRNA MEG3-DMR, which potentially account for its downregulation in tumors. Pharmacological intervention targeting DNA methylation combined with histone deacetylation restored ncRNA expression. These results contribute to the understanding of the epigenetic mechanisms controlling the DLK1-DIO3 region in thyroid cancer, highlighting the combined role of DNA methylation and histone marks in regulating the locus' expression.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The transcribed ultraconserved region uc.160+ enhances processing and A-to-I editing of the miR-376 cluster, hypermethylation improves glioma prognosis

  • Soler, Marta|||0000-0002-6656-957X
  • Davalos, Veronica|||0000-0003-4077-5137
  • Sánchez Castillo, Anaís|||0000-0003-4024-976X
  • Mora Martínez, Carlos|||0000-0002-0542-2654
  • Setién, Fernando
  • Siqueira, E.|||0000-0002-8838-2570
  • Castro de Moura, Manuel|||0000-0002-8488-5306
  • Esteller, M.|||0000-0003-4490-6093
  • Guil, Sonia|||0000-0002-2257-3331
Transcribed ultraconserved regions (T-UCRs) are noncoding RNAs derived from DNA sequences that are entirely conserved across species. Their expression is altered in many tumor types, and, although a role for T-UCRs as regulators of gene expression has been proposed, their functions remain largely unknown. Herein, we describe the epigenetic silencing of the uc.160+ T-UCR in gliomas and mechanistically define a novel RNA-RNA regulatory network in which uc.160+ modulates the biogenesis of several members of the miR-376 cluster. This includes the positive regulation of primary microRNA (pri-miRNA) cleavage and an enhanced A-to-I editing on its mature sequence. As a consequence, the expression of uc.160+ affects the downstream, miR-376-regulated genes, including the transcriptional coregulators RING1 and YY1-binding protein (RYBP) and forkhead box P2 (FOXP2). Finally, we elucidate the clinical impact of our findings, showing that hypermethylation of the uc.160+ CpG island is an independent prognostic factor associated with better overall survival in lower-grade gliomas, highlighting the importance of T-UCRs in cancer pathophysiology.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Techniques for investigating lncRNA transcript functions in neurodevelopment

  • Srinivas, Tara
  • Siqueira, E|||0000-0002-8838-2570
  • Guil, Sonia|||0000-0002-2257-3331
Long noncoding RNAs (lncRNAs) are sequences of 200 nucleotides or more that are transcribed from a large portion of the mammalian genome. While hypothesized to have a variety of biological roles, many lncRNAs remain largely functionally uncharacterized due to unique challenges associated with their investigation. For example, some lncRNAs overlap with other genomic loci, are expressed in a cell-type-specific manner, and/or are differentially processed at the post-transcriptional level. The mammalian CNS contains a vast diversity of lncRNAs, and lncRNAs are highly abundant in the mammalian brain. However, interrogating lncRNA function in models of the CNS, particularly in vivo, can be complex and challenging. Here we review the breadth of methods used to investigate lncRNAs in the CNS, their merits, and the understanding they can provide with respect to neurodevelopment and pathophysiology. We discuss remaining challenges in the field and provide recommendations to assay lncRNAs based on current methods.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Roles of lncRNAs in brain development and pathogenesis, Emerging therapeutic opportunities

  • Srinivas, Tara
  • Mathias, Carolina
  • Oliveira-Mateos, Cristina|||0000-0003-2574-7816
  • Guil, Sonia|||0000-0002-2257-3331
The human genome is pervasively transcribed, producing a majority of short and long noncoding RNAs (lncRNAs) that can influence cellular programs through a variety of transcriptional and post-transcriptional regulatory mechanisms. The brain houses the richest repertoire of long noncoding transcripts, which function at every stage during central nervous system development and homeostasis. An example of functionally relevant lncRNAs is species involved in spatiotemporal organization of gene expression in different brain regions, which play roles at the nuclear level and in transport, translation, and decay of other transcripts in specific neuronal sites. Research in the field has enabled identification of the contributions of specific lncRNAs to certain brain diseases, including Alzheimer's disease, Parkinson's disease, cancer, and neurodevelopmental disorders, resulting in notions of potential therapeutic strategies that target these RNAs to recover the normal phenotype. Here, we summarize the latest mechanistic findings associated with lncRNAs in the brain, focusing on their dysregulation in neurodevelopmental or neurodegenerative disorders, their use as biomarkers for central nervous system (CNS) diseases in vitro and in vivo, and their potential utility for therapeutic strategies.